Marketing & Strategy
Consumer watchdog to impose hefty penalties on companies and social media influencers
Marketing & Strategy: The Australian Competition and Consumer Commission (ACCC) conducted an extensive internet ‘sweep’ targeting influencer accounts across major platforms including Instagram, TikTok, Snapchat, YouTube, Facebook, and Twitch.
Focusing on seven sectors, including healthcare, the ACCC invited consumers, businesses, and industry participants to report instances of misleading conduct by influencers. A staggering 150 tip-offs were received prior to the sweep, primarily related to influencers failing to disclose commercial relationships in their posts.
Under the Australian Consumer Law (ACL), embedded within the Australian Competition and Consumer Act 2010, businesses, including social media influencers, are prohibited from misleading or deceiving consumers.
The ACCC identified various forms of misleading conduct in influencer marketing, such as:
- Non-disclosure of brand relationships in social media posts.
- Vague or confusing disclosure of brand relationships using terms like ‘sp,’ ‘spon,’ ‘sponcon,’ ‘collab,’ ‘creativepartner,’ ‘ambassador,’ and similar abbreviations.
- False or inaccurate statements about brands, products, or services.
- Other concerning conduct such as multi-level marketing schemes and subscription traps.
The report released last month showed the ACCC is concerned that “this conduct is becoming more pervasive over time as the influencer industry continues to grow”.
To address these concerns, the ACCC proposes a multi-faceted approach involving education, compliance, and enforcement activities. The commission will also release updated guidance material for influencers, brands, and advertisers.
Warning of potential enforcement actions, the ACCC emphasised the importance of compliance with the law. Breaches of the ACL can result in significant penalties, and brands found guilty of misleading or deceiving consumers may suffer severe reputational damage. Social media influencers and brands are advised to ensure their advertising, marketing, and promotional activities align fully with legal standards, particularly in the examined sectors.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Lilly’s drug cuts diabetes risk by 94%, so why is it still not on the PBS?
On World Diabetes Day (14 November), new data reveals that three years of treatment with a GIP/GLP-1 receptor agonist significantly […]
MoreNews & Trends - Biotechnology
Depaz Oration to celebrate an ‘enduring’ legacy in the biotech sector
AusBiotech announced the establishment of the Depaz Oration, an annual keynote event that will debut at the AusBiotech Conference in […]
MoreNews & Trends - Pharmaceuticals
Government calls for public input on genomic-led cancer care
The Australian Government has launched a public consultation on a draft policy framework aimed at enhancing genomics-informed cancer care nationwide. […]
MoreNews & Trends - MedTech & Diagnostics
Can the patient voice reduce low-value care? Australia’s first large-scale hospital initiative seeks answers
In an Australian-first, a not-for-profit private health insurer will ask hospital patients to rate not only their clinical care but […]
More